Testing Maternal-fetal Genotype Incompatibility With Mother-offspring Pair Data
暂无分享,去创建一个
Wenjiang J. Fu | M. Qian | R. Romero | Kelian Sun | Yuehua Cui | Ming D Li
[1] Jinbo Chen,et al. Semiparametric Maximum Likelihood Methods for Analyzing Genetic and Environmental Effects with Case‐Control Mother–Child Pair Data , 2012, Biometrics.
[2] H. Cordell,et al. Investigation of Maternal Effects, Maternal-Fetal Interactions and Parent-of-Origin Effects (Imprinting), Using Mothers and Their Offspring , 2011, Genetic epidemiology.
[3] Jinbo Chen,et al. Likelihood ratio tests for maternal and fetal genetic effects on obstetric complications , 2009, Genetic epidemiology.
[4] C R Weinberg,et al. Making the most of case-mother/control-mother studies. , 2008, American journal of epidemiology.
[5] Wenjiang J. Fu,et al. Mapping Nucleotide Sequences that Encode Complex Binary Disease Traits with HapMap , 2007, Current genomics.
[6] P. Czernichow,et al. Small for gestational age: short stature and beyond. , 2007, Endocrine reviews.
[7] G. Vovis,et al. Candidate-Gene Association Study of Mothers with Pre-Eclampsia, and Their Infants, Analyzing 775 SNPs in 190 Genes , 2006, Human Heredity.
[8] J. Lonnqvist,et al. HLA-B maternal-fetal genotype matching increases risk of schizophrenia. , 2006, American journal of human genetics.
[9] P. Zandi,et al. Rh and ABO maternal‐fetal incompatibility and risk of autism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[10] T. Paunio,et al. Incorporating Serotypes into Family Based Association Studies Using the MFG Test , 2006, Annals of human genetics.
[11] M. Freemark. Regulation of Maternal Metabolism by Pituitary and Placental Hormones: Roles in Fetal Development and Metabolic Programming , 2006, Hormone Research in Paediatrics.
[12] Raymond J Carroll,et al. Analysis of case‐control studies of genetic and environmental factors with missing genetic information and haplotype‐phase ambiguity , 2005, Genetic epidemiology.
[13] J. Sinsheimer,et al. An exact maternal‐fetal genotype incompatibility (MFG) test , 2005, Genetic epidemiology.
[14] F. Cheah,et al. The role of serum insulin-like growth factor I (IGF-I) in neonatal outcome , 2004, Journal of Clinical Pathology.
[15] Ting Chen,et al. Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. , 2004, Genome research.
[16] Peter Kraft,et al. RHD maternal–fetal genotype incompatibility and schizophrenia: extending the MFG test to include multiple siblings and birth order , 2004, European Journal of Human Genetics.
[17] P. Strisciuglio,et al. A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency , 2003, Journal of medical genetics.
[18] Janet S Sinsheimer,et al. Detecting genotype combinations that increase risk for disease: Maternal‐Fetal genotype incompatibility test , 2003, Genetic epidemiology.
[19] T. Paunio,et al. RHD maternal-fetal genotype incompatibility increases schizophrenia susceptibility. , 2002, American journal of human genetics.
[20] Yoav Ben-Shlomo,et al. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. , 2002, Diabetes.
[21] Albert Hofman,et al. Association between genetic variation in the gene for insulin-like growth factor-l and low birthweight , 2002, The Lancet.
[22] D. Dunger,et al. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. , 2000, The Journal of clinical endocrinology and metabolism.
[23] A. Hattersley,et al. The fetal insulin hypothesis: an alternative explanation of the association of low bir thweight with diabetes and vascular disease , 1999, The Lancet.
[24] J. Graham,et al. Evaluation of neonates born with intrauterine growth retardation: review and practice guidelines. , 1998, Journal of perinatology : official journal of the California Perinatal Association.
[25] T. Ludwig,et al. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. , 1996, Developmental biology.
[26] E. Reece,et al. The Relation Between Human Fetal Growth and Fetal Blood Levels of Insulin‐Like Growth Factors I and II, Their Binding Proteins, and Receptors , 1994, Obstetrics and gynecology.
[27] Elizabeth J. Robertson,et al. Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.
[28] J. Verhaeghe,et al. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. , 1993, American journal of obstetrics and gynecology.
[29] A. Scott,et al. Constrained and unconstrained fetal growth: associations with some biological and pathological factors. , 1988, Annals of human biology.
[30] I. Mackenzie,et al. Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. , 1985, Acta endocrinologica.
[31] E. Ritvo,et al. Autism and shared parental HLA antigens. , 1985, Journal of the American Academy of Child Psychiatry.
[32] P. Magnus. Causes of variation in birth weight: A study of offspring of twins , 1984, Clinical genetics.
[33] R. Girot,et al. [Neonatal thrombopenia with feto maternal incompatibility in the HL-A system]. , 1973, Revue francaise de transfusion.
[34] V. Kulich,et al. [Hemolytic disease of a newborn caused by anti-k antibody]. , 1967, Ceskoslovenska pediatrie.
[35] Wenjiang J. Fu,et al. Statistical Applications in Genetics and Molecular Biology A Regularized Regression Approach for Dissecting Genetic Conflicts that Increase Disease Risk in Pregnancy , 2011 .
[36] K. Nicolaides,et al. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. , 1995, The Journal of clinical endocrinology and metabolism.
[37] M S Kramer,et al. Determinants of low birth weight: methodological assessment and meta-analysis. , 1987, Bulletin of the World Health Organization.